The incidence of complications of acute pancreatitis is high in patien
ts with endotoxemia, and so we determined the endotoxin levels in the
blood and peritoneal fluid of patients with acute severe pancreatitis
to correlate the levels with any sequelae. Fourteen patients with acut
e severe pancreatitis were examined with regard to clinical features,
biochemical tests, and laparotomy (n = 9). In all coagulation profiles
, blood gas analysis, chest and abdominal x-rays, ultrasound, and abdo
minal computed tomography scan (n = 10) were performed. Qualitative es
timation of endotoxin levels was done in peripheral blood and peritone
al and peripancreatic fluid. Ten (71.42%) of 14 patients had endotoxin
in the blood, and 9 (64.28%) had it in the peritoneal fluid. Twelve (
85.7%) had pulmonary involvement, with hypoxia being the most common (
85.7%); among them endotoxin was found in the blood of 10 (83.32%) and
in the peritoneal fluid of 8 (66.66%) patients. Renal dysfunction was
found in 4 (28.57%) patients; endotoxin was present in the blood of a
ll 4 patients and in the peritoneal fluid of 3 (75%) patients. Cardiov
ascular abnormality was detected in 8 (57.14%) patients, and endotoxin
was present in the blood and peritoneal fluid of all patients. Metabo
lic abnormality was present in 8 (57.14%) patients; endotoxin was pres
ent in the blood of all 8 patients and in the peritoneal fluid of 7 (8
7.6%) patients. Eight (88.88%) of the 9 patients who required surgery
had endotoxemia. Three (30%) patients with endotoxemia survived, where
as all 4 patients without endotoxemia survived. Mean hospital stay was
61.2 days and 46.7 days for endotoxin-positive and endotoxin-negative
patients, respectively. We conclude that the presence of endotoxin in
blood and peritoneal fluid correlates with the severity, systemic com
plications, and mortality rates of acute pancreatitis. Endotoxin estim
ation can identify patients at risk in the early stages of acute pancr
eatitis.